The world has lost a voice of unmatched eloquence and integrity. – The Lewis family Anyone who met Stephen Lewis, knows that these words epitomize a man whose blend of optimism and action, inspired the world to tackle HIV/AIDS head-on and with urgency. If you were fortunate enough to hear him speak in-person, you couldn’t
Delegates call on Prime Minister to end the Canadian epidemic and lead the worldwide HIV response in light of dramatic US cuts to treatment and care Vancouver, BC, June 6, 2025: The BC Centre for Excellence in HIV/AIDS (BC-CfE) is hosting a national Summit of medical and HIV experts to raise the alarm about the
New study, published in Lancet Public Health, points to immediate need to address structural and socio-economic impacts on health for women with HIV
New research, published in Lancet HIV, shows that providing antiretroviral treatment to all people living with HIV and preventive treatment to individuals at high-risk of contracting HIV reduces deaths and new HIV infections by more than 90% Vancouver, BC: The BC Centre for Excellence in HIV/AIDS (BC-CfE) has released a new research study showing that
December 1st marks World AIDS Day and the start of Indigenous AIDS Awareness Week. Today, the BC Centre for Excellence in HIV/AIDS (BC-CfE) is proud to announce the virtual end of the domestic epidemic of HIV in British Columbia.
The doxycycline initiative is the first program of its kind in Canada in response to the doubling of syphilis rates since 2020 Vancouver, B.C. – The BC Centre for Excellence in HIV/AIDS (BC-CfE) is proud to announce the launch of a new Doxycycline initiative for the prevention of bacterial sexually transmitted infections including syphilis, gonorrhea
The BC Centre for Excellence in HIV/AIDS (BC-CfE) launched an integrated program in Vancouver’s Downtown East Side for individuals living with chronic pain who are diagnosed with opioid use disorder.
Today, July 28th, is World Hepatitis Day, a day to raise awareness of the global burden of viral hepatitis and also to influence meaningful change in delivering care to those living with the virus. The theme this year is ‘Hepatitis Can’t Wait’.
The Treatment Optimization of Psychosis (TOP) Collaborative, launching today, is a quality improvement (QI) initiative led by the BC Centre for Excellence in HIV/AIDS (BC-CfE) in partnership with Vancouver Coastal Health’s (VCH) Mental Health and Substance Use Services.
The BC Centre for Excellence in HIV/AIDS (BC-CfE) Committee for Drug Evaluation and Therapy (CDET) has completed the evaluation of available data regarding the use of the four COVID-19 vaccines currently approved in Canada for persons living with HIV (PLWH). Those four vaccines are the Pfizer-BioNTech and Moderna, which are mRNA vaccines, and the AstraZeneca and Janssen, which are viral vector vaccines.
The BC Centre for Excellence in HIV/AIDS (BC-CfE) is grateful for the funding awarded by Health Canada’s Substance Use and Addictions Program (SUAP). The $3.6M for 2020 to 2023 will support an evidence-informed innovative Safer Drug Supply Program at the BC-CfE’s Hope to Health Research & Innovation Complex in Vancouver’s Downtown Eastside (DTES).
The BC Centre for Excellence in HIV/AIDS (BC-CfE) Committee for Drug Evaluation and Therapy (CDET) has completed the evaluation of the available data regarding the use of Pfizer and Moderna COVID-19 mRNA vaccines for persons living with HIV (PLWH).
Dr. Jeffrey Joy, senior research scientist with the BC Centre for Excellence in HIV/AIDS (BC-CfE) and an assistant professor of medicine at the University of British Columbia is leading a team of researchers in the fight against COVID-19. As of today, COVID-19 has claimed more than 40,000 lives globally, and at least 823,000 people have been infected.
Inspired by the dramatic reduction in HIV rates in BC, the BOOST Collaborative is working to increase the number of people on effective opioid agonist therapy across BC
The BC Centre for Excellence in HIV/AIDS welcomes the federal government’s worldwide leadership and strong commitment to The Global Fund
The latest findings from a major international study support the already strong case that consistent and sustained HIV antiretroviral treatment prevents new HIV infections. In findings released in The Lancet, the PARTNER study found no cases of HIV transmission through condomless sex among gay couples in which one partner was living with HIV on treatment and the other was HIV-negative. These results follow previous PARTNER study findings showing no cases of HIV transmission in more than 58,000 instances of condomless sex among serodiscordant homosexual and heterosexual couples.
A study from the BC Centre for Excellence in HIV/AIDS (BC-CfE) uncovered new opportunities in the health care system to diagnose individuals living with HIV. In 2017, nearly a quarter of those diagnosed with HIV in BC had a CD4 count that was low, a major indicator of a weakened immune system and advanced HIV disease.
Dr. Glenda Gray, a world-leading expert who is spearheading global efforts towards an HIV vaccine, will be speaking at Simon Fraser University’s President’s Dream Colloquium on HIV/AIDS on March 11.
The BC-CfE is optimistic about the encouraging announcement that a second person has been cleared of HIV. As in the first case, this was achieved through a bone-marrow transplant from a donor harbouring a rare mutation in the human CCR5 gene. The CCR5 is necessary for HIV to enter cells in the human body as it acts as a receptor.
Research from the BC Centre for Excellence in HIV/AIDS (BC-CfE) has found that a higher proportion of individuals living with HIV have experienced osteoporosis-related factures (ORF) compared to HIV-negative individuals (6.08% versus 5.45%).
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
